Related Experiment Video
Updated: Aug 9, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Interaction of Moloney murine leukemia virus matrix protein with IQGAP
Juliana Leung1, Andrew Yueh, Frank S K Appah
1Integrated Program in Cellular, Molecular, and Biophysical Studies, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Abstract:
The matrix protein (MA) of the Moloney murine leukemia virus (M-MuLV) was found to interact with IQGAP1, a prominent regulator of the cytoskeleton. Mutational studies defined residues of MA critical for the interaction, and tests of viruses carrying MA mutations revealed a near-perfect correlation between binding and virus replication. The replication-defective mutants showed defects in both early and late stages of the life cycle. Four viable second-site revertant viruses were isolated from three different replication-defective parental mutants, and in all cases the interaction with IQGAP1 was restored by the suppressor mutations. The interaction of MA and IQGAP1 was readily detected in vitro and in vivo. Virus replication was potently inhibited by a C-terminal fragment of IQGAP1, and impaired by RNAi knockdown of IQGAP1 and 2. We suggest that the IQGAPs link the virus to the cytoskeleton for trafficking both into and out of the cell.
Insights
Moloney murine leukemia virus matrix protein (MA) binds IQGAP1, a cytoskeleton regulator. This interaction is crucial for virus replication, with defects in binding halting the viral life cycle.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- The Moloney murine leukemia virus (M-MuLV) matrix protein (MA) plays a role in viral assembly and entry.
- IQGAP1 is a key regulator of the actin cytoskeleton, influencing cell shape, motility, and intracellular trafficking.
Purpose of the Study:
- To investigate the interaction between M-MuLV MA and IQGAP1.
- To determine the functional significance of this interaction for M-MuLV replication.
Main Methods:
- Site-directed mutagenesis of M-MuLV MA to identify critical interaction residues.
- Virus replication assays to assess the impact of MA mutations.
- In vitro and in vivo binding assays to confirm MA-IQGAP1 interaction.
- RNA interference (RNAi) to knockdown IQGAP1 expression.
Main Results:
- Specific residues in M-MuLV MA were identified as critical for IQGAP1 binding.
- Mutations disrupting MA-IQGAP1 interaction led to replication-defective viruses with defects in multiple life cycle stages.
- Second-site revertant viruses restored IQGAP1 binding and replication competence.
- IQGAP1 knockdown or inhibition with a C-terminal fragment impaired virus replication.
Conclusions:
- The interaction between M-MuLV MA and IQGAP1 is essential for efficient virus replication.
- IQGAP1 likely facilitates viral trafficking by linking the virus to the host cell cytoskeleton.
- Targeting the MA-IQGAP1 interaction could be a strategy for antiviral therapy.

